Manipulating Milestones In Pandemic Times With AGTC's Sue Washer
Business Of Biotech12/21/20 • 37 min
We love to hear from our listeners. Send us a message.
The COVID-19 pandemic continues to disrupt biopharma clinical trials, especially those conducted with at-risk patient populations. From patient recruitment to data collection, clinical trials execution became considerably more challenging in 2020. On this episode of The Business Of Biotech, AGTC CEO Sue Washer gives us a behind-the-scenes look at the creative measures her company took to serve a geographically dispersed clinical patient population and ensure her company met clinical milestones.
Access this and hundreds of episodes of the Business of Biotech videocast under the Listen & Watch tab at bioprocessonline.com.
Subscribe to our monthly Business of Biotech newsletter.
Get in touch with guest and topic suggestions: [email protected]
Find Matt Pillar on LinkedIn: https://www.linkedin.com/in/matthewpillar/
12/21/20 • 37 min
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/business-of-biotech-176344/manipulating-milestones-in-pandemic-times-with-agtcs-sue-washer-13717089"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to manipulating milestones in pandemic times with agtc's sue washer on goodpods" style="width: 225px" /> </a>
Copy